Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-028374
Filing Date
2025-02-27
Accepted
2025-02-27 07:45:25
Documents
84
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K hrtx-20241231.htm   iXBRL 10-K 3178481
2 EX-4.4 hrtx-ex4_4.htm EX-4.4 41166
3 EX-10.3 hrtx-ex10_3.htm EX-10.3 110020
4 EX-10.4 hrtx-ex10_4.htm EX-10.4 87739
5 EX-10.5 hrtx-ex10_5.htm EX-10.5 81816
6 EX-10.6 hrtx-ex10_6.htm EX-10.6 501879
7 EX-19.1 hrtx-ex19_1.htm EX-19.1 80232
8 EX-23.1 hrtx-ex23_1.htm EX-23.1 5009
9 EX-31.1 hrtx-ex31_1.htm EX-31.1 17067
10 EX-31.2 hrtx-ex31_2.htm EX-31.2 16987
11 EX-32.1 hrtx-ex32_1.htm EX-32.1 10626
12 GRAPHIC img165138206_0.jpg GRAPHIC 191202
  Complete submission text file 0000950170-25-028374.txt   14260633

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hrtx-20241231.xsd EX-101.SCH 1516855
87 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20241231_htm.xml XML 2610615
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33221 | Film No.: 25673074
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)